The Contact Allergen Methylisothiazolinone (MIT) is a Potent Activator of the TRPA1 Ion Channel

Area of Science:

• Immunology
• Neuroscience
• Dermatology

Background:

• Methylisothiazolinone (MIT) is a common preservative and biocide.
• MIT is a known inducer of allergic contact dermatitis.
• Transient receptor potential ankyrin 1 (TRPA1) channels mediate itch, pain, and inflammation.

Purpose of the Study:

• To investigate if TRPA1 is activated by MIT.
• To determine if TRPA1 mediates MIT-induced inflammatory conditions.

Main Methods:

• Intracellular calcium measurements using Fluo 3-AM.
• Whole-cell patch clamp recordings.
• In vivo studies using a mouse model of MIT-induced paw edema and TRPA1-deficient mice.

Main Results:

• MIT dose-dependently increased intracellular calcium, inhibited by a TRPA1 antagonist.
• MIT activated TRPA1 channels, with specific cysteine mutations reducing potency.
• TRPA1-deficient mice and those treated with a TRPA1 antagonist showed reduced MIT-induced paw edema.
• TRPA1 deficiency decreased IL-4 expression in skin following MIT exposure.

Conclusions:

• MIT is a potent agonist of TRPA1.
• TRPA1 mediates key inflammatory effects of MIT.
• TRPA1 plays a role in Th2-skewed contact allergy pathogenesis.
• TRPA1 represents a potential drug target for Th2-driven diseases.